Brilacidin is modeled after defensin proteins in terms of
Brilacidin is modeled after defensin proteins in terms of its polarity and biologic activity. Defensin proteins, like many proteins, are less stable.They are chains of amino acids which are held together with relatively weak chemical bonds. They are more likely to be damaged by digestive processes such as gastric acidity and intestinal processes. They have a shorter duration of action.They are expensive to produce and have been difficult to develop into pharmaceuticals even after decades of study.
Brilacidin is based on the chemical structure of a defensin, Magainin. Magainin was discovered by Michael Zasloff who attempted to develop it into an antibiotic. After several years he was frustrated in his research by the limitations outlined above.
Polymedix Researchers recognized these short comings and were able to replace the weaker peptide core with a more stable core consisting of stronger chemical aromatic rings and by using amides {arylamides} which allowed Brilacidin to be more stable but maintain its defensin like abilities. By biochemically altering the structure and using a supercomputer to predict how molecular changes in the alignment of its biologically active hyrophillic positive side with its negatively charge side they were able to increase its biologically activity many times over.
They studied scores of compounds this way and Brilacidin was unique in its abilities such as:
1.A strong antibiotic active against gram positive and some gram negative bacteria.
2.Immunomodulating characteristics to control the inflammatory efforts of the bodies immune system in a positive way.
3. The antiviral effects are currently being studied and to date have been initially positive with future studies to delineate its place as a possible treatment.
4. Multiple human studies have shown it to be safe.
5. Studies such as immune passage studies show it is less likely to develop bacterial resistance.
Dr Degrado and his team's goal was to mimic and improve the biologic actions of a a natural antibiotic in order to capture its biologic actions which have been honed by eons of evolution. Past studies have shown them to be successful; future studies may show researchers have only scratched the surface of its potential.
10
2
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...
Continue Reading
HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...
Continue Reading
JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...
Continue Reading
TA Services Moves Boldly Across Borders If ever there was a time to play the logistics chessboard like a champ, it's now, and TA Services just slammed the board with a solid move. They've grabbed Carmen Pacheco Transportation and Interload Forwarding, two family-run operations with some real muscle in North American logistics. This isn't a small-time maneuver; they've...
Continue Reading
In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...
Continue Reading
Has anyone else noticed just how fast the world spins when it comes to consumer trends these days? Bob Evans is hopping right on the protein bandwagon with its latest launch, a microwave-ready Protein Macaroni & Cheese that packs 18 grams of protein per serving. You gotta hand it to them for seizing opportunity when they see it. This one's not just about tossing a new...
Continue Reading
Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...
Continue Reading
NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...
Continue Reading
Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...
Continue Reading
Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...
Continue Reading
Top 5 Most Recently Viewed Articles
Transforming Audio for Italian Media GEDI, one of Italy's leading media companies, is changing the way newspapers present news to their readers. By incorporating fresh audio content features, they’re responding to the rising demand for audio formats. This shift is not just about keeping up; it’s about creating value in the reader's experience. Introducing Voice...
Continue Reading
Xanadu Takes a Significant Step Forward in Quantum Technology Xanadu Quantum Technologies Inc., renowned for its innovative work in photonic quantum computing, has made headlines by advancing to Stage B of DARPA's Quantum Benchmarking Initiative. This prestigious progression not only emphasizes Xanadu's prominent role in the future of quantum computing but also secures...
Continue Reading
Fluor Corporation Investors Take Action Amid Legal News In light of recent developments, investors in Fluor Corporation should be aware of their rights and potential actions they can take concerning their investments. The firm, known for its significant contributions to the infrastructure sector, is presently under scrutiny due to allegations regarding undisclosed...
Continue Reading
Lead Real Estate Co., Ltd to Participate in Investor Conference Lead Real Estate Co., Ltd (NASDAQ: LRE), a leading Japanese luxury real estate developer, is gearing up for an exciting event as it announces its participation in an important virtual investor conference. The Sidoti Year End Virtual Investor Conference is set to take place on December 10-11, providing...
Continue Reading
FDA Approves Biocon Biologics' New Biosimilars Biocon Biologics Ltd., a prominent player in the biosimilars market and a subsidiary of Biocon Ltd., has reached a significant milestone in its mission to provide affordable biologic therapies. The company recently received approval from the U.S. Food and Drug Administration (FDA) for its new biosimilars, Bosaya™ and...
Continue Reading
